temporal contrast sensitivity test |
90 |
|
Tenon’s cyst, Ahmed Glaucoma Valve disc |
implant 309 |
|
|
|
TIGR/myocilin gene |
122 |
|
|
timolol |
16, 228 |
|
|
|
combination therapy 234–5 |
|
|
preservative-free formulation |
228 |
|
tonography |
|
|
|
pseudofacility 22 |
|
|
|
Schiotz tonometer |
20–2, 21–2 |
|
|
tonometry |
|
|
|
artifacts, corneal abnormalities |
210, 211 |
Perkin applanation tonometer |
210 |
|
pneumotonometry |
36, 36 |
|
|
intraocular pressure measurement |
210 |
pulsatile blood flow device (POBF) |
188 |
see also intraocular pressure measurement |
Tonopen |
36, 36, 37 |
|
|
|
intraocular pressure measurement 36, 36, 37 |
topographic change analysis, stereometric parameter change 83, 84
trabecular meshwork
junction of filtering and non-filtering trabecular
meshwork |
247 |
|
outflow of aqueous humor 17, 41, 44 |
pigmentary glaucomas |
133–5, 134, 243 |
trabecular outflow of aqueous humor 20–3 |
outflow pathways 16–18, 17 |
trabecular meshwork |
17, 41, 44 |
trabeculectomy |
261–78 |
|
block 267
combined phacotrabeculectomy 318–19 complications associated 292–3 elevated episcleral venous pressure 147 fornix-based 264
laser suture lysis 248–59
resolving suprachoroidal hemorrhage following 148 see also filtration surgery
trabeculo-Descemet’s window (TDW)
filtration function |
279 |
|
microperforations during surgery |
279, 284 |
postoperative care |
283 |
|
trabeculoplasty |
|
|
argon laser (ALT) |
245–8 |
|
selective laser (SLT), ALT vs SLT |
249 |
trabeculotomy, developmental glaucoma 326–7,
327, 328
Traube Hering waves, oculo-ophthalmodynamamography 189
trauma 49
angle recession 56 differential diagnosis 220
birth 214
child abuse, optic nerve atrophy 212, 220 cyclodialysis cleft causing hypotony maculopathy
56, 255–6, 266 hyphema 140, 141 lens dislocation 163
post-traumatic glaucomas 138–41 travoprost 16, 226
treatment see medical therapy
UGH (uveitis, glaucomas, hyphema)
syndrome |
137, 139 |
|
ultrasound biomicroscopy (UBM) 149 |
iridovitreal block |
150 |
|
pigmentary glaucomas |
135 |
unoprostone 16, 227–8 |
|
uveal melanoma |
144–5 |
|
uveitis |
|
|
|
and glaucoma |
166 |
|
idiopathic uveitis |
143 |
|
inflammatory glaucomas |
142–3 |
sarcoid 145 |
|
|
|
uveitis-related anterior synechiae, UBM 166
uveoscleral outflow |
17–18, 23–5 |
ciliary muscle effects |
18 |
|
intracameral tracer infusion |
25 |
measurement 25 |
|
|
|
viscocanalostomy (VC) |
279, 280 |
anesthesia 282 |
|
|
|
closure of superficial flap |
288 |
complications 292–3 |
|
|
diamond blades |
280 |
|
|
intubation of Schlemm’s canal 283 |
outcomes 289–91 |
|
|
|
patient selection |
281–2, 281 |
postoperative management, immediate/long term
283–94 |
|
|
|
|
|
|
|
|
UBM analysis of scleral lake |
294 |
|
|
visual field defects |
93, 93–113 |
|
|
|
asymmetrical visual field defects loss |
96–7 |
asymmetry across horizontal meridian |
101 |
|
automated static perimetry |
95 |
|
|
broad inferior arcuate scotoma |
103 |
|
|
development of new defects |
109 |
|
|
diffuse depression |
96–8 |
|
|
|
|
|
double arcuate scotoma |
104 |
|
|
|
early glaucomatous damage in inferior |
|
|
hemifield 102 |
|
|
|
|
|
|
extension of dense superior nerve-fiber bundle |
defect |
113 |
|
|
|
|
|
|
|
far-advanced glaucomatous optic |
|
|
neuropathy |
107, 112 |
|
|
|
|
fluctuation |
99 |
|
|
|
|
|
|
|
gradual enlargement of superior nasal step |
111 |
high intraocular pressure |
|
107 |
|
|
incidence |
93 |
|
|
|
|
|
|
|
inferior arcuate scotoma |
103 |
|
|
|
isolated paracentral defects |
100 |
|
|
isolated temporal defects |
|
106 |
|
|
loss of axon bundle |
104 |
|
|
|
|
|
nasal steps |
102, 111 |
|
|
|
|
|
nerve-fiber bundle defects |
105 |
|
|
new defects |
109 |
|
|
|
|
|
|
|
normal visual field and mapping methods |
94 |
normal-tension glaucoma |
|
174–7 |
|
|
POAG 125–7 |
|
|
|
|
|
|
|
progression |
108 |
|
|
|
|
|
|
|
steady decline of 1dB per year |
107, 112 |
|
superior altitudinal defect |
106, 113 |
|
|
